Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

[Formula: see text]Long-term neurodevelopmental outcome after prenatal exposure to maternal hematological malignancies with or without cytotoxic treatment

M. van Gerwen, E. Huis In 't Veld, M. van Grotel, MM. van den Heuvel-Eibrink, K. Van Calsteren, C. Maggen, V. Drochytek, G. Scarfone, C. Fontana, R. Fruscio, E. Cardonick, EM. van Dijk-Lokkart, F. Amant

. 2021 ; 27 (6) : 822-833. [pub] 20210420

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22003982

Data on the long-term neurodevelopmental outcomes of children exposed to hematological maternal cancer with or without treatment during pregnancy are lacking. A total of 57 children, of whom 33 males and 24 females, prenatally exposed to hematological malignancies and its treatment, were invited for neuropsychological and physical examinations at 18 months, 36 months, 6, 9, 12, 15 and 18 years of age. Oncological, obstetrical, neonatal and follow-up data of these children were collected. Parents were asked to complete questionnaires on their child's general health, school performances, social situation, behavioral development, executive functioning, and if their child receives supportive care. Non-Hodgkin lymphoma was diagnosed in 35.1%, Hodgkin lymphoma in 28.1%, acute myeloid leukemia in 15.8%, chronic myeloid leukemia in 12.3%, and acute lymphoblastic leukemia in 8.8%. Cognitive development at a median age of 10.7 years was within the normal range. In subgroup analyses of children in early childhood, the gestational age at birth was correlated with the cognitive outcome at a median age of 1.7 years. Scores for language development, intelligence, attention, memory and behavior, as well as clinical neurological and general pediatric examinations were within normal ranges. In subgroup analyses, the need for supportive care in the child was associated with the loss of the mother. Prenatal exposure to hematological maternal malignancies with or without treatment did not affect the neurodevelopment of the child in the long term. Yet, caution is indicated and surveillance of the emotional development of the child is needed, especially when the mother is deceased to cancer.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003982
003      
CZ-PrNML
005      
20220127145650.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/09297049.2021.1902489 $2 doi
035    __
$a (PubMed)33876721
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a van Gerwen, Mathilde $u Center for Gynecologic Oncology Amsterdam, the Netherlands Cancer Institute, Amsterdam, The Netherlands $u Pediatric Oncology , Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
245    10
$a [Formula: see text]Long-term neurodevelopmental outcome after prenatal exposure to maternal hematological malignancies with or without cytotoxic treatment / $c M. van Gerwen, E. Huis In 't Veld, M. van Grotel, MM. van den Heuvel-Eibrink, K. Van Calsteren, C. Maggen, V. Drochytek, G. Scarfone, C. Fontana, R. Fruscio, E. Cardonick, EM. van Dijk-Lokkart, F. Amant
520    9_
$a Data on the long-term neurodevelopmental outcomes of children exposed to hematological maternal cancer with or without treatment during pregnancy are lacking. A total of 57 children, of whom 33 males and 24 females, prenatally exposed to hematological malignancies and its treatment, were invited for neuropsychological and physical examinations at 18 months, 36 months, 6, 9, 12, 15 and 18 years of age. Oncological, obstetrical, neonatal and follow-up data of these children were collected. Parents were asked to complete questionnaires on their child's general health, school performances, social situation, behavioral development, executive functioning, and if their child receives supportive care. Non-Hodgkin lymphoma was diagnosed in 35.1%, Hodgkin lymphoma in 28.1%, acute myeloid leukemia in 15.8%, chronic myeloid leukemia in 12.3%, and acute lymphoblastic leukemia in 8.8%. Cognitive development at a median age of 10.7 years was within the normal range. In subgroup analyses of children in early childhood, the gestational age at birth was correlated with the cognitive outcome at a median age of 1.7 years. Scores for language development, intelligence, attention, memory and behavior, as well as clinical neurological and general pediatric examinations were within normal ranges. In subgroup analyses, the need for supportive care in the child was associated with the loss of the mother. Prenatal exposure to hematological maternal malignancies with or without treatment did not affect the neurodevelopment of the child in the long term. Yet, caution is indicated and surveillance of the emotional development of the child is needed, especially when the mother is deceased to cancer.
650    12
$a protinádorové látky $7 D000970
650    _2
$a dítě $7 D002648
650    _2
$a vývoj dítěte $7 D002657
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    12
$a hematologické nádory $x komplikace $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a inteligence $7 D007360
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a matky $7 D009035
650    _2
$a těhotenství $7 D011247
650    12
$a zpožděný efekt prenatální expozice $7 D011297
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Huis In 't Veld, Evangeline $u Center for Gynecologic Oncology Amsterdam, the Netherlands Cancer Institute, Amsterdam, The Netherlands $u Pediatric Oncology , Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a van Grotel, Martine $u Pediatric Oncology , Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a van den Heuvel-Eibrink, Marry M $u Pediatric Oncology , Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
700    1_
$a Van Calsteren, Kristel $u Department of Obstetrics, University Hospitals Leuven, Leuven and Department of Development and Regeneration, KU Leuven, Leuven, Belgium
700    1_
$a Maggen, Charlotte $u Department of Oncology, KU Leuven, Leuven, Belgium
700    1_
$a Drochytek, Vit $u Department of Obstetrics and Gynecology, 3rd Medical Faculty Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Scarfone, Giovanna $u Gynecological Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
700    1_
$a Fontana, Camilla $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, NICU, Milan, Italy
700    1_
$a Fruscio, Robert $u Clinic of Obstetrics and Gynecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy
700    1_
$a Cardonick, Elyce $u Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, NJ, USA
700    1_
$a van Dijk-Lokkart, Elisabeth M $u Department of Child & Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Amant, Frédéric $u Center for Gynecologic Oncology Amsterdam, the Netherlands Cancer Institute, Amsterdam, The Netherlands $u Department of Oncology, KU Leuven, Leuven, Belgium $u Center for Gynecologic Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands
773    0_
$w MED00006292 $t Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence $x 1744-4136 $g Roč. 27, č. 6 (2021), s. 822-833
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33876721 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145647 $b ABA008
999    __
$a ok $b bmc $g 1751442 $s 1155131
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 27 $c 6 $d 822-833 $e 20210420 $i 1744-4136 $m Child neuropsychology $n Child Neuropsychol $x MED00006292
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options